DRITIPRIME MF Tablets
DRITIPRIME MF is a combination medicine containing Drotaverine Hydrochloride and Mefenamic Acid. It is formulated to help manage pain associated with smooth muscle spasms.
Drotaverine acts as an antispasmodic agent, while Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) with analgesic properties.
This medicine should be used strictly as directed by a registered medical practitioner.
Composition
Each film-coated tablet contains:
Drotaverine Hydrochloride IP – 80 mg
Mefenamic Acid IP – 250 mg
Excipients – q.s.
Colour: Erythrosine.
Pricing Details
Key Benefits
Combines Drotaverine Hydrochloride and Mefenamic Acid.
Combines antispasmodic and analgesic properties.
Film-coated tablet formulation.
Intended to help manage pain associated with spasms.
For use under medical supervision.
Indications
Pain associated with smooth muscle spasms.
Abdominal cramps, when prescribed by a healthcare professional.
Use only as directed by a registered medical practitioner.
Enquire Now
Request pricing, bulk order details, or custom packaging for this product.